My Heart Will Go On: Management of calcium channel blocker and beta blocker toxicity

Clare Cycz, Pharm.D.

My Heart Will Go On: Management of calcium channel blocker and beta blocker toxicity

Schedule:      October 21, 2021, 2:30 to 3:30pm Live Virtual, Boston, MA

Audience:       Accredited for Pharmacists and Technicians

                       Other interested health care professionals welcome

Credits:         1 Contact Hour of knowledge-based 1.0 CEUs will be awarded under the provider

Presenter:    Clare Cycz, Pharm.D., PGY2 Critical Care Pharmacy Resident Beth Israel Deaconess Medical Center

No charge for CE

Learning Objectives for Pharmacists:


After attending this program, participants will be able to:

  1. Describe the pharmacokinetics and to toxicokinetics associated with beta blockers and calcium channel blockers
  2. Identify interventions for beta blocker and/or calcium channel blocker toxicity and highlight those that have shown to improve mortality
  3. Discuss the use of high dose insulin euglycemic therapy for a patient with beta blocker and/or calcium channel blocker toxicity

Learning Objectives for Technicians:


  1. Identify medications associated with mortality benefit in CCB/BB overdose
  2. Express the importance of timely medication compounding and delivery for patients with CCB/BB overdose
  3. Review sterile compounding methods/guidelines for glucagon and high dose insulin therapy

Requirements for Receiving CE Credit:

  • Successful completion of post presentation questions
  • Participation at live program
  • Complete program online evaluation form
  • NABP #

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.